Seamus Mulligan, founder of Adapt Pharma, serves as Chairman and Chief Executive Officer. Previously, Seamus was founder, Chairman, and Chief Executive Officer of Azur Pharma, which merged with Jazz Pharmaceuticals plc in 2012. Seamus continues to serve on the Board of Directors at Jazz Pharmaceuticals. Over a 20-year period prior to founding Azur Pharma, Seamus was closely involved with Élan Corporation’s growth and evolution from a drug delivery company into a research-focused pharmaceutical organization. Seamus holds a Bachelor of Science in Pharmaceuticals and a Master of Science from Trinity College, Dublin, Ireland.